Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

5 clinical studies listed.

Filters:

Intellectual Disability, Mild to Moderate

Tundra lists 5 Intellectual Disability, Mild to Moderate clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT07517016

Real-Time Pose Recognition Technology for Improving Tennis Learning in Individuals With Intellectual Disabilities

This study investigates the effect of real-time pose recognition technology on learning tennis skills in individuals with mild to moderate intellectual disabilities. The study compares two training methods: traditional face-to-face tennis instruction and training supported by real-time pose recognition technology. Thirty participants aged 12-18 from special education institutions in Burdur, Turkey, were randomly assigned to either the experimental group using the technology or a control group receiving traditional instruction. The study aims to determine whether the use of real-time pose recognition improves tennis skill accuracy, learning speed, attention, and motivation compared to traditional methods.

Gender: All

Ages: 12 Years - 18 Years

Updated: 2026-04-08

1 state

Intellectual Disability, Mild to Moderate
Adolescence
NOT YET RECRUITING

NCT07505121

Comparing the Impact of Peer Support vs. Staff-Delivered Transportation Interventions for Young Adults With Intellectual and Developmental Disabilities.

This clinical trial will look at whether young adults with intellectual and developmental disabilities (YA-IDD) have better outcomes when a travel training intervention called Ready to Ride (R2R) is taught by a specially trained Peer Supporter (PS) who shares the lived experience of having an IDD than YA-IDD who are taught Ready to Ride by staff at their community services organization. The aspects of life being looked at are loneliness, satisfaction with social activities, travel skills, service use and access, employment, and health related quality of life. The researchers think the following things will happen. 1. YA-IDD who learn from a Peer Supporter will report significantly higher satisfaction with social activities, increased social connectedness and significantly less loneliness compared to YA who are taught organization staff. 2. Both groups will learn the same amount of travel skills. 3. YA-IDD who learn from a Peer Supporter will show larger increases in access to community-based services, transportation use, employment and health related services after 4 months than the YA taught by organizational staff.

Gender: All

Ages: 18 Years - 27 Years

Updated: 2026-04-01

3 states

Intellectual Disability, Mild to Moderate
Developmental Disability
ACTIVE NOT RECRUITING

NCT07385157

Ultra-long-term EEG Monitoring in PwID

Many people with intellectual disabilities (PwID) have seizures. Electroencephalography (EEG), which measures the brain's electrical activity, is a key method of diagnosing and assessing seizures but can be difficult and uncomfortable for PwID. UNEEG medical has developed a very small device ('SubQ') that can be put under the skin on a person's head to track their brain activity without staying in the hospital. It has been implanted for 15 months successfully in people with seizures but not in PwID. The aim of this project is to use learnings from previous co-production work to test how well the device can detect seizures in people with mild to moderate ID and to assess its safety and impact on quality of life and behaviour. The project will also look into carer and clinican experiences using the system and its potential usefulness and cost impact. Having an accurate means of identifying seizures is particularly important for people with mild to moderate ID because they cannot always tell us about their experiences in a meaningful manner. This means that seizures are more likely to be missed or attributed to behavioural issues. Healthcare professionals will identify eligible patients to be invited to participate in the study. These patients will be diagnosed with mild to moderate ID, but will have the capacity to consent to take part in the study. The patients who participate in the study will have the UNEEG SubQ device implanted under the skin on their scalp. Ongoing EEG data from the device will be collected and be compared with seizure diaries. The project will also examine any behaviour issues and quality of life using surveys before implantation as well as immediately, 3-months, and 6-months after. The patients, their carers and healthcare professionals will be invited to focus groups to share their experiences with the technology.

Gender: All

Ages: 18 Years - Any

Updated: 2026-02-03

Epilepsy
Intellectual Disability, Mild to Moderate
NOT YET RECRUITING

NCT07092852

PGx Medication Safety Reviews of Persons With IDD

The purpose of this study is to assess the feasibility of a comprehensive medication review and PGx initiative as part of the care process for individuals in the care of CP Unlimited. This initiative may help improve management of medications and overall health and well-being for participating individuals. Please note that in the context of the research being conducted, all information will remain confidential and deidentified for analyses. Under the proposed study protocol, CP Unlimited, in partnership with pharmacists at GalenusRx, will implement and assess a comprehensive medication safety and PGx initiative. Almost three quarters of all clinical trials have eligibility criteria resulting in the exclusion of adults with IDD. This study will help address ongoing health practice disparity. As indicated above, the investigators are requesting the authorization of the guardian or representative, on behalf of the participant under their supervision, to enroll this individual in the proposed study because she/he is currently prescribed medications or may eventually receive prescribed or over-the-counter medications. Hereinafter, the denomination "he/she, him/her, his/her or them/their" will be used to refer to the individual with IDD. The response to medication can be affected by variations in our genes and by other medications and various disease conditions. Information contained in our genes can vary from one patient to another patient and this can explain why we all can respond differently to medications. Genetic testing and a review of his/her medications can help to determine if the medication will work for him/her. PGx is how his/her genes affect the way he/she responds to specific drugs. PGx can tell if he/she is more or less likely to feel bad reactions to a drug, or if a drug is likely to benefit him/her and be safe for him/her to take. Knowing his/her genetic information and all medicines that he/she is taking can help his/her pharmacist and his/her doctor find the combination of medicines that will work the best for him/her, now and in the future.

Gender: All

Ages: 21 Years - Any

Updated: 2025-07-30

2 states

Intellectual Disability, Mild
Intellectual Disability, Mild to Moderate
Developmental Disability
RECRUITING

NCT06592404

The (Cost)Effectiveness of a Social Robot for Persons with Problems in Daily Structure and Planning in Disability Care

The goal of this multiple baseline single case study is to study the (cost)effectiveness of a social robot in reducing professional caregiver support and promoting independence for individuals in long-term disability care experiencing problems with daily structure and planning. The main research questions it aims to answer are: * What is the effect of the social robot on the frequency of moments professional caregivers support individuals experiencing problems with daily structure and planning with the execution of daily activities, compared to care as usual, after 6 weeks? * Does the effect of the social robot persist in the long term (after 6 months)? * What is the cost-effectiveness of the social robot? Participants will: * Use a social robot in their daily living environment * Answer survey questions about their quality of life and wellbeing during the study period * Share their experiences in interviews Their profesional caregivers will: * Register the frequency and duration of support they provide to the participant daily for 13 weeks and a 2-week follow-up * Give weekly updates and score participants' goal attainment while using the social robot * Fill in questionnaires on participants' productivity and health care consumption during the study period * Share their experiences in interviews

Gender: All

Ages: 18 Years - Any

Updated: 2024-09-19

3 states

Brain Injury, Chronic
Intellectual Disability, Mild to Moderate
Autism Spectrum Disorder
+1